-
1دورية أكاديمية
المؤلفون: Som, Sumit, Deford, Cassandra C., Kaiser, Mandi L., Terrell, Deirdra R., Kremer Hovinga, Johanna A., Lämmle, Bernhard, George, James N., Vesely, Sara K.
المصدر: Transfusion; Dec2012, Vol. 52 Issue 12, p2525-2532, 8p, 6 Charts
مصطلحات موضوعية: THROMBOTIC thrombocytopenic purpura treatment, PLASMA exchange (Therapeutics), DISEASE complications, LONGITUDINAL method, CENTRAL venous catheters, DATA analysis
-
2دورية أكاديمية
المؤلفون: Page, Evaren E.1,2, Kremer Hovinga, Johanna A.3, Terrell, Deirdra R.1, Vesely, Sara K.1, George, James N.1,2 james-george@ouhsc.edu
المصدر: Blood. 6/16/2016, Vol. 127 Issue 24, p3092-3094. 3p.
مصطلحات موضوعية: *RITUXIMAB, *THROMBOTIC thrombocytopenic purpura treatment, *PLASMA exchange (Therapeutics), *ADRENOCORTICAL hormones, *HEMOSTASIS
-
3دورية أكاديمية
المؤلفون: Eder, Anne F., Som, Sumit, Deford, Cassandra C., Kaiser, Mandi L., Terrell, Deirdra R., Kremer Hovinga, Johanna A., Lämmle, Bernhard, George, James N., Vesely, Sara K.
المصدر: Transfusion; Dec2012, Vol. 52 Issue 12, p2524-2524, 1p
مصطلحات موضوعية: THROMBOTIC thrombocytopenic purpura treatment, QUESTIONS & answers
-
4دورية أكاديمية
المؤلفون: Scully, M.1, Cataland, S. R.2, Peyvandi, F.3, Coppo, P.4, Knöbl, P.5, Hovinga, J. A. Kremer6, Metjian, A.7, de la Rubia, J.8, Pavenski, K.9, Callewaert, F.10, Biswas, D.10, De Winter, H.10, Zeldin, R. K.10 hilde.dewinter@ablynx.com, Scully, Marie11, Cataland, Spero R11, Peyvandi, Flora11, Coppo, Paul11, Knöbl, Paul11, Kremer Hovinga, Johanna A11, Metjian, Ara11
المصدر: New England Journal of Medicine. 1/24/2019, Vol. 380 Issue 4, p335-346. 12p.
مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GINGIVAL hyperplasia, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *PLASMA exchange (Therapeutics), *RESEARCH, *THROMBOTIC thrombocytopenic purpura, *EVALUATION research, *BODY mass index, *RANDOMIZED controlled trials, *BLIND experiment, *PLATELET count, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents
-
5دورية أكاديمية
المؤلفون: Peyvandi, Flora1,2, Scully, Marie3,4, Hovinga, Johanna A. Kremer5,6, Cataland, Spero7, Knöbl, Paul8, Haifeng Wu9, Artoni, Andrea1, Westwood, John-Paul3, Taleghani, Magnus Mansouri5,6, Jilma, Bernd10, Callewaert, Filip11 filip.callewaert@ablynx.com, Ulrichts, Hans12, Duby, Christian11, Tersago, Dominique11, Kremer Hovinga, Johanna A (AUTHOR), Wu, Haifeng (AUTHOR), Mansouri Taleghani, Magnus (AUTHOR), TITAN Investigators (CORPORATE AUTHOR)
المصدر: New England Journal of Medicine. 2/11/2016, Vol. 374 Issue 6, p511-522. 12p.
مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *BLOOD platelet aggregation, *PLASMA exchange (Therapeutics), *TREATMENT effectiveness, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GLYCOPROTEINS, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *RESEARCH, *RESEARCH funding, *THROMBOTIC thrombocytopenic purpura, *DISEASE relapse, *EVALUATION research, *RANDOMIZED controlled trials, *DISEASE remission, *BLIND experiment, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents